Form 3667 fda-2025

Get Form
form 3667 fda Preview on Page 1

Here's how it works

01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

How to use or fill out form 3667 fda with our platform

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2
  1. Click ‘Get Form’ to open Form FDA 3667 in the editor.
  2. In Part I, indicate whether your submission is a new GRAS notice or an amendment. Also, confirm that all files are free of viruses and provide relevant dates for prior communications with the FDA.
  3. Move to Part II to identify the notifier and any authorized agents. Ensure you include accurate contact information for effective communication.
  4. In Part III, specify the substance name, submission format, and transmission mode. Indicate if you are referring to existing information in FDA files.
  5. Describe the intended use of the substance in Part IV, ensuring clarity on its application.
  6. Provide identifying details about the substance in Part V, including chemical names and registry numbers.
  7. Complete Part VI by checking off additional elements required for your GRAS notice that are not covered in previous sections.
  8. Finalize by signing in Part VII and listing all attachments in Part VIII. Use our platform’s features to easily insert file names for electronic submissions.

Start using our platform today to streamline your form completion process for free!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
FDA Form 482 is a form used by the Food and Drug Administration (FDA) in the pharmaceutical industry. This form is used to inform the manufacturing site of an audit that is about to take place. This form is also known as a Notice of Inspection (NOI) form. According to Food and Drug Cosmetic Act (FDA) Section No.
Contrary to popular belief, FDA does not approve food, beverages, or dietary supplements before they are sold in the United States. Food facilities do not need certification or premarket approval, but most must register with FDA and comply with the Food Safety Modernization Act (FSMA).
FDA may conduct an inspection of your operation for a variety of reasons, such as a routinely scheduled investigation, a survey, or a response to a reported problem. The investigator will present credentials and Notice of Inspection (FDA Form 482) upon arriving at your plant.
The Inspector will record all responses and findings in an Establishment Inspection Report (EIR). The FDA Inspector will show their badge with their credentials and issue a completed Form FDA 482 (Notice of Inspection).
In January 2021, following discussions with EORTC, NCI have launched a new International Investigator Statement (IIS) in the Registration and Credential Repository (RCR) for European countries. This statement replaces the Form FDA 1572 for participation in US NCTN and NCORP trials that are not under IND.

People also ask

During an inspection, OII investigators may observe conditions they deem to be objectionable. These observations, are listed on an FDA Form 483 when, in an investigators judgment, the observed conditions or practices indicate that an FDA-regulated product may be in violation of FDAs requirements.
The Accredited Third-Party Certification Program is a voluntary program in which FDA recognizes accreditation bodies that will have the responsibility of accrediting third-party certification bodies. The certification bodies will conduct food safety audits and issue certifications of foreign food facilities.

Related links